Compile Data Set for Download or QSAR
Report error Found 30 Enz. Inhib. hit(s) with all data for entry = 50028328
TargetCannabinoid receptor 2(Human)
Boehringer Ingelheim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50257799(rac-2-(methyl((2'-(trifluoromethyl)biphenyl-4-yl)m...)
Affinity DataEC50:  2nMAssay Description:Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP releaseMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCannabinoid receptor 2(Human)
Boehringer Ingelheim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50258007((S)-N-(2,4-dichlorophenyl)-5-((2-phenylmorpholino)...)
Affinity DataEC50:  10nMAssay Description:Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP releaseMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCannabinoid receptor 2(Human)
Boehringer Ingelheim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50258006((S)-N-(3,4-dichlorophenyl)-5-((2-phenylmorpholino)...)
Affinity DataEC50:  50nMAssay Description:Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP releaseMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCannabinoid receptor 2(Human)
Boehringer Ingelheim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50258005((S)-N-(biphenyl-4-yl)-5-((2-phenylmorpholino)methy...)
Affinity DataEC50: >2.00E+4nMAssay Description:Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP releaseMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCannabinoid receptor 2(Human)
Boehringer Ingelheim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50258004((S)-N1,N1-dimethyl-N4-(5-((2-phenylmorpholino)meth...)
Affinity DataEC50: >2.00E+4nMAssay Description:Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP releaseMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCannabinoid receptor 2(Human)
Boehringer Ingelheim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50257961((S)-N-(4-methoxyphenyl)-5-((2-phenylmorpholino)met...)
Affinity DataEC50:  65nMAssay Description:Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP releaseMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCannabinoid receptor 2(Human)
Boehringer Ingelheim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50257960((S)-N-(4-isopropylphenyl)-5-((2-phenylmorpholino)m...)
Affinity DataEC50: >2.00E+4nMAssay Description:Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP releaseMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCannabinoid receptor 2(Human)
Boehringer Ingelheim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50257959((S)-5-((2-phenylmorpholino)methyl)-N-p-tolylpyridi...)
Affinity DataEC50:  100nMAssay Description:Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP releaseMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCannabinoid receptor 2(Human)
Boehringer Ingelheim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50257958((S)-N-(4-fluorophenyl)-5-((2-phenylmorpholino)meth...)
Affinity DataEC50:  35nMAssay Description:Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP releaseMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCannabinoid receptor 2(Human)
Boehringer Ingelheim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50257957((S)-N-(4-chlorophenyl)-5-((2-phenylmorpholino)meth...)
Affinity DataEC50:  30nMAssay Description:Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP releaseMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCannabinoid receptor 2(Human)
Boehringer Ingelheim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50257914((S)-N-(3-chlorophenyl)-5-((2-phenylmorpholino)meth...)
Affinity DataEC50:  200nMAssay Description:Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP releaseMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCannabinoid receptor 2(Human)
Boehringer Ingelheim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50257913((S)-N-(2-chlorophenyl)-5-((2-phenylmorpholino)meth...)
Affinity DataEC50:  30nMAssay Description:Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP releaseMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCannabinoid receptor 2(Human)
Boehringer Ingelheim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50257911((S)-N-phenyl-5-((2-phenylmorpholino)methyl)pyridin...)
Affinity DataEC50:  140nMAssay Description:Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP releaseMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCannabinoid receptor 2(Human)
Boehringer Ingelheim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50211843(GW-842166 | 2-(2,4-dichlorophenylamino)-4-trifluor...)
Affinity DataEC50:  350nMAssay Description:Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP releaseMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCannabinoid receptor 2(Human)
Boehringer Ingelheim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50257800(rac-2-phenyl-4-((2'-(trifluoromethyl)biphenyl-4-yl...)
Affinity DataEC50:  330nMAssay Description:Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP releaseMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCannabinoid receptor 2(Human)
Boehringer Ingelheim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50257801(rac-3-phenyl-1-((2'-(trifluoromethyl)biphenyl-4-yl...)
Affinity DataEC50:  30nMAssay Description:Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP releaseMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCannabinoid receptor 2(Human)
Boehringer Ingelheim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50257802((S)-2-phenyl-4-((2'-(trifluoromethyl)biphenyl-4-yl...)
Affinity DataEC50:  40nMAssay Description:Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP releaseMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCannabinoid receptor 2(Human)
Boehringer Ingelheim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50257850((S)-4-((2'-chlorobiphenyl-4-yl)methyl)-2-phenylmor...)
Affinity DataEC50:  25nMAssay Description:Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP releaseMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCannabinoid receptor 2(Human)
Boehringer Ingelheim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50257851((S)-4-((2',3'-dichlorobiphenyl-4-yl)methyl)-2-phen...)
Affinity DataEC50:  6nMAssay Description:Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP releaseMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCannabinoid receptor 2(Human)
Boehringer Ingelheim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50257852((S)-4-((2'-chloro-5'-methylbiphenyl-4-yl)methyl)-2...)
Affinity DataEC50:  3nMAssay Description:Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP releaseMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCannabinoid receptor 2(Human)
Boehringer Ingelheim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50257853((S)-4'-((2-phenylmorpholino)methyl)biphenyl-2-carb...)
Affinity DataEC50:  3nMAssay Description:Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP releaseMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCannabinoid receptor 2(Human)
Boehringer Ingelheim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50257854((S)-N-phenyl-4-((2-phenylmorpholino)methyl)aniline...)
Affinity DataEC50:  615nMAssay Description:Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP releaseMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCannabinoid receptor 2(Human)
Boehringer Ingelheim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50257910((S)-4-(4-phenoxybenzyl)-2-phenylmorpholine | CHEMB...)
Affinity DataEC50:  1.50E+4nMAssay Description:Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP releaseMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCannabinoid receptor 2(Human)
Boehringer Ingelheim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50257912((S)-N-(2,3-dichlorophenyl)-5-((2-phenylmorpholino)...)
Affinity DataEC50:  1.60E+3nMAssay Description:Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP releaseMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCannabinoid receptor 2(Human)
Boehringer Ingelheim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50257851((S)-4-((2',3'-dichlorobiphenyl-4-yl)methyl)-2-phen...)
Affinity DataKi:  104nMAssay Description:Displacement of [3H]Win55212 form human CB2 receptor transfected in HEK cellsMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCannabinoid receptor 2(Human)
Boehringer Ingelheim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50257851((S)-4-((2',3'-dichlorobiphenyl-4-yl)methyl)-2-phen...)
Affinity DataKi:  312nMAssay Description:Displacement of [3H]CP-55940 form human CB2 receptor transfected in HEK cellsMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCannabinoid receptor 2(Human)
Boehringer Ingelheim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50258007((S)-N-(2,4-dichlorophenyl)-5-((2-phenylmorpholino)...)
Affinity DataKi:  2.65E+3nMAssay Description:Displacement of [3H]Win55212 form human CB2 receptor transfected in HEK cellsMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCannabinoid receptor 2(Human)
Boehringer Ingelheim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50211843(GW-842166 | 2-(2,4-dichlorophenylamino)-4-trifluor...)
Affinity DataKi: >5.00E+3nMAssay Description:Displacement of [3H]CP-55940 form human CB2 receptor transfected in HEK cellsMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCannabinoid receptor 2(Human)
Boehringer Ingelheim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50258007((S)-N-(2,4-dichlorophenyl)-5-((2-phenylmorpholino)...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [3H]CP-55940 form human CB2 receptor transfected in HEK cellsMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCannabinoid receptor 2(Human)
Boehringer Ingelheim Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50211843(GW-842166 | 2-(2,4-dichlorophenylamino)-4-trifluor...)
Affinity DataKi: >1.00E+4nMAssay Description:Displacement of [3H]Win55212 form human CB2 receptor transfected in HEK cellsMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed